scholarly article | Q13442814 |
P2093 | author name string | Karin Sauer | |
Jacob R. Chambers | |||
P2860 | cites work | Extracellular DNA chelates cations and induces antibiotic resistance in Pseudomonas aeruginosa biofilms | Q21090518 |
Microbial biofilms: from ecology to molecular genetics | Q21999032 | ||
Microbial biofilms | Q22255624 | ||
Biofilms: survival mechanisms of clinically relevant microorganisms | Q22299328 | ||
Pseudomonas aeruginosa displays multiple phenotypes during development as a biofilm | Q24538827 | ||
The transition metal gallium disrupts Pseudomonas aeruginosa iron metabolism and has antimicrobial and antibiofilm activity | Q24683150 | ||
Bacterial biofilms: a common cause of persistent infections | Q27861033 | ||
Determination of minimum inhibitory concentrations | Q28203149 | ||
Bacterial Biofilms: An Emerging Link to Disease Pathogenesis | Q28207244 | ||
Antibiotic resistance of bacteria in biofilms | Q28207706 | ||
A novel signaling network essential for regulating Pseudomonas aeruginosa biofilm development | Q28471924 | ||
The two-component system CprRS senses cationic peptides and triggers adaptive resistance in Pseudomonas aeruginosa independently of ParRS | Q28492572 | ||
Cationic antimicrobial peptides activate a two‐component regulatory system, PmrA‐PmrB, that regulates resistance to polymyxin B and cationic antimicrobial peptides in Pseudomonas aeruginosa | Q28492717 | ||
Adaptive resistance to the "last hope" antibiotics polymyxin B and colistin in Pseudomonas aeruginosa is mediated by the novel two-component regulatory system ParR-ParS | Q28493107 | ||
The MerR-like transcriptional regulator BrlR contributes to Pseudomonas aeruginosa biofilm tolerance | Q28493235 | ||
Comprehensive transposon mutant library of Pseudomonas aeruginosa | Q29614861 | ||
Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients | Q29615301 | ||
Active starvation responses mediate antibiotic tolerance in biofilms and nutrient-limited bacteria | Q33716417 | ||
Antimicrobial resistance of Pseudomonas aeruginosa biofilms | Q33973957 | ||
Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin | Q33979968 | ||
Characterization of phenotypic changes in Pseudomonas putida in response to surface-associated growth | Q33996997 | ||
Role of membranes in the activities of antimicrobial cationic peptides | Q34111592 | ||
Parallel evolution in Pseudomonas aeruginosa over 39,000 generations in vivo. | Q34128914 | ||
Colistin-tobramycin combinations are superior to monotherapy concerning the killing of biofilm Pseudomonas aeruginosa | Q34143161 | ||
Characterization of temporal protein production in Pseudomonas aeruginosa biofilms | Q34150961 | ||
Probing prokaryotic social behaviors with bacterial "lobster traps" | Q34285911 | ||
The single-nucleotide resolution transcriptome of Pseudomonas aeruginosa grown in body temperature | Q34426518 | ||
Role of nutrient limitation and stationary-phase existence in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin | Q34884476 | ||
Pseudomonas aeruginosa: resistance to the max | Q35084559 | ||
Characterization of colony morphology variants isolated from Streptococcus pneumoniae biofilms | Q35759418 | ||
Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections | Q36095874 | ||
The agmR gene, an environmentally responsive gene, complements defective glpR, which encodes the putative activator for glycerol metabolism in Pseudomonas aeruginosa | Q36164134 | ||
Formation of Streptococcus pneumoniae non-phase-variable colony variants is due to increased mutation frequency present under biofilm growth conditions | Q36933242 | ||
The MerR-like regulator BrlR confers biofilm tolerance by activating multidrug efflux pumps in Pseudomonas aeruginosa biofilms | Q37035909 | ||
P. aeruginosa Biofilms in CF Infection | Q37176167 | ||
Characterization of nutrient-induced dispersion in Pseudomonas aeruginosa PAO1 biofilm | Q37583328 | ||
Influence of growth rate on susceptibility to antimicrobial agents: biofilms, cell cycle, dormancy, and stringent response | Q38037106 | ||
Contribution of the PhoP-PhoQ and PmrA-PmrB two-component regulatory systems to Mg2+-induced gene regulation in Pseudomonas aeruginosa. | Q38313207 | ||
Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-oprM efflux pumps in Pseudomonas aeruginosa | Q39475663 | ||
Interactions between biocide cationic agents and bacterial biofilms | Q39651576 | ||
Microbial characterization of biofilms in domestic drains and the establishment of stable biofilm microcosms | Q39743016 | ||
Involvement of a novel efflux system in biofilm-specific resistance to antibiotics | Q39759278 | ||
Two-component regulatory systems can interact to process multiple environmental signals | Q39843585 | ||
Dynamic interactions of biofilms of mucoid Pseudomonas aeruginosa with tobramycin and piperacillin | Q39874925 | ||
Genome macrorestriction analysis of diversity and variability of Pseudomonas aeruginosa strains infecting cystic fibrosis patients. | Q40188725 | ||
Outer membrane protein H1 of Pseudomonas aeruginosa: involvement in adaptive and mutational resistance to ethylenediaminetetraacetate, polymyxin B, and gentamicin | Q40336613 | ||
PmrAB, a two-component regulatory system of Pseudomonas aeruginosa that modulates resistance to cationic antimicrobial peptides and addition of aminoarabinose to lipid A | Q40387809 | ||
PAS domain residues and prosthetic group involved in BdlA-dependent dispersion response by Pseudomonas aeruginosa biofilms | Q41583285 | ||
The novel two-component regulatory system BfiSR regulates biofilm development by controlling the small RNA rsmZ through CafA | Q42161859 | ||
Pseudomonas aeruginosa cross-colonization and persistence in patients with cystic fibrosis. Use of a DNA probe | Q42232660 | ||
PhoP-PhoQ homologues in Pseudomonas aeruginosa regulate expression of the outer-membrane protein OprH and polymyxin B resistance | Q42613861 | ||
In vitro effects of antimicrobial agents on planktonic and biofilm forms of Staphylococcus lugdunensis clinical isolates | Q42948712 | ||
Persister cells and tolerance to antimicrobials | Q44735515 | ||
Broad-host-range expression vectors that carry the L-arabinose-inducible Escherichia coli araBAD promoter and the araC regulator | Q47987335 | ||
Comparison of the PhoPQ regulon in Escherichia coli and Salmonella typhimurium | Q50091022 | ||
Role of Pseudomonas aeruginosa PhoP-phoQ in resistance to antimicrobial cationic peptides and aminoglycosides. | Q54034376 | ||
Interactions of an antimicrobial peptide, magainin 2, with outer and inner membranes of Gram-negative bacteria | Q54562301 | ||
Characterization and use of a DNA probe as an epidemiological marker for Pseudomonas aeruginosa | Q70316490 | ||
Peptide antibiotics | Q73073957 | ||
Membrane permeabilization mechanisms of a cyclic antimicrobial peptide, tachyplesin I, and its linear analog | Q73561279 | ||
P433 | issue | 20 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Pseudomonas aeruginosa | Q31856 |
colistin | Q418946 | ||
biofilm | Q467410 | ||
P304 | page(s) | 4678–4688 | |
P577 | publication date | 2013-10-01 | |
P1433 | published in | Journal of Bacteriology | Q478419 |
P1476 | title | The MerR-like regulator BrlR impairs Pseudomonas aeruginosa biofilm tolerance to colistin by repressing PhoPQ | |
P478 | volume | 195 |
Q37552351 | Advances in understanding Pseudomonas |
Q29346796 | BrlR from Pseudomonas aeruginosa is a c-di-GMP-responsive transcription factor |
Q55517510 | BrlR from Pseudomonas aeruginosa is a receptor for both cyclic di-GMP and pyocyanin. |
Q57944093 | Chronic tonsillitis and biofilms: a brief overview of treatment modalities |
Q92302893 | Clinical Use of Colistin in Biofilm-Associated Infections |
Q47098155 | Divide and conquer: the Pseudomonas aeruginosa two-component hybrid SagS enables biofilm formation and recalcitrance of biofilm cells to antimicrobial agents via distinct regulatory circuits |
Q41036943 | Efflux-mediated resistance to a benzothiadiazol derivative effective against Burkholderia cenocepacia |
Q92302854 | Mechanisms of Polymyxin Resistance |
Q64910479 | Molecular mechanisms related to colistin resistance in Enterobacteriaceae. |
Q40975034 | Osteoarticular infection caused by MDR Pseudomonas aeruginosa: the benefits of combination therapy with colistin plus β-lactams |
Q42027703 | Polymyxin Susceptibility in Pseudomonas aeruginosa Linked to the MexXY-OprM Multidrug Efflux System |
Q38922536 | Polymyxin: Alternative Mechanisms of Action and Resistance. |
Q37589273 | Rapid adaptation drives invasion of airway donor microbiota by Pseudomonas after lung transplantation. |
Q49908061 | Recent perspectives on the molecular basis of biofilm formation by Pseudomonas aeruginosa and approaches for treatment and biofilm dispersal |
Q92429968 | Resistance and Heteroresistance to Colistin in Pseudomonas aeruginosa Isolates from Wenzhou, China |
Q46293888 | Structure, function and regulation of Pseudomonas aeruginosa porins. |
Q50261169 | Susceptibility of Pseudomonas aeruginosa Dispersed Cells to Antimicrobial Agents Is Dependent on the Dispersion Cue and Class of the Antimicrobial Agent Used |
Q47406005 | The ABC of biofilm drug tolerance: The MerR-like regulator BrlR is an activator of ABC transport systems, with PA1874-77 contributing to the tolerance by Pseudomonas aeruginosa biofilms to tobramycin |
Q63346843 | The PA3177 Gene Encodes an Active Diguanylate Cyclase That Contributes to Biofilm Antimicrobial Tolerance but Not Biofilm Formation by Pseudomonas aeruginosa |
Q28493140 | The Pseudomonas aeruginosa diguanylate cyclase GcbA, a homolog of P. fluorescens GcbA, promotes initial attachment to surfaces, but not biofilm formation, via regulation of motility |
Q54977625 | The Yin and Yang of SagS: Distinct Residues in the HmsP Domain of SagS Independently Regulate Biofilm Formation and Biofilm Drug Tolerance. |
Q28493226 | The diguanylate cyclase GcbA facilitates Pseudomonas aeruginosa biofilm dispersion by activating BdlA |
Search more.